| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/26/2004 | WO2004006831A3 Method and device for inducing biological processes by micro-organs |
| 08/26/2004 | WO2004000207A3 Toxin-phage bacteriocide antibiotic and uses thereof |
| 08/26/2004 | WO2003088905A3 Compositions and minimally invasive methods for treating incomplete tissue repair |
| 08/26/2004 | WO2003087296A3 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 08/26/2004 | WO2003077859A3 Method of inducing an enhanced immune response against hiv |
| 08/26/2004 | US20040167634 Prosthetic kidney and its use for treating kidney disease |
| 08/26/2004 | US20040167078 Agents for improving lipid metabolism and reducing high blood pressure |
| 08/26/2004 | US20040167074 Therapeutic applications of mFLINT polypeptides |
| 08/26/2004 | US20040167062 such as anxiety disorder, attention deficit/hyperactivity disorder, autistic disorder, bipolar disorder, major depression, mood disorder, pervasive developmental disorder, psychotic disorder and schizophrenia by administering an antimicrobial composition optionally with a probiotic mixture |
| 08/26/2004 | US20040166559 Vectors for gene therapy |
| 08/26/2004 | US20040166170 Topical applying of wound healing agents; antiulcer agents |
| 08/26/2004 | US20040166169 Inserts; repair damage tissue; particles suspended in liquid; compaction; centrifuging; freeze drying |
| 08/26/2004 | US20040166122 Adenovirus formulations |
| 08/26/2004 | US20040166109 Modulator polypeptide for regulation of intracellular endocytosis of amyloid precursor proteins; diagnosis and treatment of neurodegenerative disorders |
| 08/26/2004 | US20040166103 Treatment of malignant tumor |
| 08/26/2004 | US20040166101 Culture product containing Lactobacillus, streptococcus and carbohydrates; fermentated probiotic mixtures |
| 08/26/2004 | US20040166100 Treatment for arthritis |
| 08/26/2004 | US20040166098 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 08/26/2004 | US20040166097 Therapy for bone disease or lung defect |
| 08/26/2004 | US20040166096 Therapy for bone disorders; stem cells differentiated to gene expression of chondrocytes in biocompatible liquid |
| 08/26/2004 | US20040166095 Graft versus host disease; administering lymphocytes ,hematopoietic stem cells |
| 08/26/2004 | US20040166092 Use of viral vectors and charged molecules for gene therapy |
| 08/26/2004 | DE4119288B4 Verfahren zur Schichtenfiltration von pharmazeutischen, biologischen, chemischen oder dergleichen Flüssigkeiten Process for the layers filtration of pharmaceutical, biological, chemical, or the like liquids |
| 08/26/2004 | CA2640585A1 Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol{4,4}-non-ene-4-one |
| 08/26/2004 | CA2515594A1 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| 08/26/2004 | CA2515208A1 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/25/2004 | EP1449920A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 08/25/2004 | EP1449540A1 Cytokine-inducing material and cytokine-inducing instrument |
| 08/25/2004 | EP1449535A1 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 08/25/2004 | EP1448995A1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 08/25/2004 | EP1448771A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 08/25/2004 | EP1448770A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 08/25/2004 | EP1448765A2 Matrix for the production of tissue engineered ligaments, tendons and other tissue |
| 08/25/2004 | EP1448763A1 Characterization and isolation of subsets of human embryonic stem cells (hes) and cells associated or derived therefrom |
| 08/25/2004 | EP1448598A2 Novel immunogenic mimetics of multimer proteins |
| 08/25/2004 | EP1448583A2 A novel g protein-coupled receptor, gave8 |
| 08/25/2004 | EP1448247A1 Creation of tissue engineered female reproductive organs |
| 08/25/2004 | EP1448229A2 Pharmaceutical composition for inducing an immune response in a human or animal |
| 08/25/2004 | EP1448224A2 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 08/25/2004 | EP1448220A2 Antiphlogistic agent and the use thereof |
| 08/25/2004 | EP1448219A1 Antiglaucomatous agent and use thereof |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448211A1 A composition for lowering the concentration of intestinal pathogenic peptides |
| 08/25/2004 | EP1448179A1 Substituted bicyclo 3.3.1 nonan-2,4,9-triones as pharmaceutical active ingredients |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP1448053A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 08/25/2004 | EP1448052A1 Anti-pathogenic composition useful in blood preservation |
| 08/25/2004 | EP1221853A4 Oligodendrocyte cell cultures and methods for their preparation and use |
| 08/25/2004 | EP1185612B1 Bioreactor design and process for engineering tissue from cells |
| 08/25/2004 | EP1177157A4 A vital matter and a producing method |
| 08/25/2004 | EP0852463A4 Myogenic differentiation of human mesenchymal stem cells |
| 08/25/2004 | EP0826051B1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
| 08/25/2004 | CN1524088A A virus causing respiratory tract illness in susceptible mammals |
| 08/25/2004 | CN1523999A DNA expression vectors and methods of use |
| 08/25/2004 | CN1523995A Preventives and/or remedies for fish infections |
| 08/25/2004 | CN1522727A Prostate hyperplasia pharmaceutical and method for making same |
| 08/25/2004 | CN1522711A Enterobacteria containing tablet |
| 08/25/2004 | CN1522709A Honey containing biological selenium conversion method |
| 08/25/2004 | CN1163595C Process for inactivation of viruse with aid of acridine or acridine derivative |
| 08/25/2004 | CN1163594C Stimulation of hematopoietic cell in vitro |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/25/2004 | CN1163508C Process for producing inhibin of tumor blood vessel formation |
| 08/25/2004 | CN1163257C Skin injury regenerating medicine and its preparing process |
| 08/25/2004 | CN1163252C Tumour assistantly therapeutic drug and its preparing process |
| 08/25/2004 | CN1163251C Drug for treating gastritis |
| 08/25/2004 | CN1163249C 眼部营养素 Eye nutrients |
| 08/25/2004 | CN1163244C Navel-adminstering formulation for curing intractable ascites of liver cirrhosis |
| 08/25/2004 | CN1163243C Prepared pill of traditional Chinese medicine for treating hepatism |
| 08/25/2004 | CN1163242C Heart nourishing capsule and its preparing process |
| 08/25/2004 | CN1163239C Medicine for treating gynopathy |
| 08/24/2004 | US6780641 Genetically modified human embryonic cells using a viral vector encoding an oncogene, can express active cytokines, chemokines, and other cytotoxic and neurotoxic substances; used for screening of compounds for diseases |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780624 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 08/24/2004 | US6780612 Methods for the propagation of lytic organisms |
| 08/24/2004 | US6780438 Colostrum; promotes resistance to fresh infection, suppression of existing infection, stimulation of immune function, and the increase of tissue repair and healing. |
| 08/24/2004 | US6780406 Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
| 08/24/2004 | CA2114338C Prescription diet composition for pet animals |
| 08/19/2004 | WO2004070044A1 Biologically-active-molecule-enriched photosynthetic micro-organisms, preparation method thereof and uses of same |
| 08/19/2004 | WO2004070041A1 Vectors for expression of toxins |
| 08/19/2004 | WO2004070023A1 Anterior ocular-associated cell sheet, three-dimensional construct and process for producing the same |
| 08/19/2004 | WO2004069178A2 Anti-inflammatory activity from lactic acid bacteria |
| 08/19/2004 | WO2004069172A2 Multilineage-inducible cells and uses thereof |
| 08/19/2004 | WO2004069156A2 Inactivated probiotic bacteria and methods of use thereof |
| 08/19/2004 | WO2004068969A1 Enteral composition for the prevention and/or treatment of sepsis |
| 08/19/2004 | WO2004058323A3 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 08/19/2004 | WO2004047770A3 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 08/19/2004 | WO2003053217A3 Tissue graft compositions and methods for producing same |
| 08/19/2004 | WO2003037260A3 Methods and compositions for treating parkinson's disease |
| 08/19/2004 | WO2003025149A8 Cell populations which co-express cd49c and cd90 |
| 08/19/2004 | US20040162417 Nucleotide sequences coding metalloenzyme for use in detergents, therapeutic, cosmetics, leather processing, solubilizing or softening agents, foods, meat modifiers, feeds and oil and fat seperating agents |
| 08/19/2004 | US20040162248 Preparation and diabetic use of gibberellins |
| 08/19/2004 | US20040162244 Novel peptides use as angiotensin converting enzyme inhibitor and preparation process thereof |
| 08/19/2004 | US20040161849 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 08/19/2004 | US20040161843 Administering a peptide fragments from proteins that function as T-cell epitopes of human cytomegalovirus(HCMV) in human are capable of directing human cytotoxic T lymphocytes (CTL) to recognize and lyse human cells to infection with HCMV |
| 08/19/2004 | US20040161806 Cells having transferred proteins, and methods of use thereof |
| 08/19/2004 | US20040161786 Gene panel participative in hepatic stellate cell activation |
| 08/19/2004 | US20040161480 Antiinflammatory agents; repair of damage tissue; mixture of metabolites and plant extracts; synergistic mixture of chondroitin sulfate and glucosamine |
| 08/19/2004 | US20040161433 Method for in vitro culture of lymphocytes and composition for use in immune therapy |
| 08/19/2004 | US20040161422 Nutritional compositions comprising probiotics |
| 08/19/2004 | US20040161421 Intramyocardial injection of autologous bone marrow |